Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 628

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 628
---
 |                  -

# |   |            -# |   |        -$ |   | Date       |
| Imran Alibhai, Ph.D.  |   | 01/16/2019 |   | 12/01/2018   |   |           1,550,000 |   |             — |   |      0.09 |   | 01/15/2029 |
| ​                     |   | 01/30/2021 |   | 01/01/2020   |   |              15,000 |   |             — |   |      0.09 |   | 01/29/2031 |
| ​                     |   | 12/16/2021 |   | 06/04/2021   |   |           1,050,000 |   |       150,000 |   |      0.63 |   | 12/15/2031 |
| John Kauh, M.D.       |   | 01/12/2023 |   | 01/30/2023   |   |             264,561 |   |       287,568 |   |      0.82 |   | 01/11/2033 |
| Dan Conn, J.D., M.B.A |   | 02/04/2022 |   | 01/12/2022   |   |             484,166 |   |       179,834 |   |      0.63 |   | 02/03/2032 |

| (1) | All of the option awards were granted under the 2018 Plan, the terms of which plan are described below under “— Equity Benefit Plans — 2018 Stock Incentive Plan.” |

| (2) | Stock option awards vest over a period of four years with 25% of the shares underlying the option vesting on the one-year anniversary of the vesting commencement date and 1/48th of the shares underlying the option vesting on a monthly basis thereafter, subject to continued service through each vesting date. |

Awards held by certain of Tvardi named executive officers are eligible for accelerated vesting under specified circumstances. Please see the subsection titled “— Potential Payments and Benefits Upon Termination or Change in Control” below for a description of such potential acceleration. Pension Benefits Tvardi’s named executive officers did not participate in